Simple Summary Since neuroaxonal damage and loss are observed in chemotherapy-induced
peripheral neuropathy (CIPN) and results in permanent disability, detecting and …

Orphan drug development is a rapidly expanding field. Nevertheless, clinical trials for rare
diseases can present inherent challenges. Optimal study design and partnerships between …

McArdle disease is caused by recessive mutations in PYGM gene. The condition is considered
to cause a “pure” muscle phenotype with symptoms including exercise intolerance, …

Diagnostic whole genome sequencing (WGS) is increasingly used in rare diseases. However,
standard, semi-automated WGS analysis may overlook diagnoses in complex disorders. …

Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication
related to taxanes. Underlying mechanisms are not completely understood and no specific …

A rapidly expanding catalog of neurogenetic disorders has encouraged a diagnostic shift
towards early clinical whole exome sequencing (WES). Adult primary mitochondrial diseases (…

Parkinson’s disease is the second most common neurodegenerative disease. Mitochondrial
dysfunction has been associated with neurodegeneration in Parkinson’s disease, and …

Mitochondrial stroke-like episodes (SLEs) are a hallmark of mitochondrial encephalomyopathy,
lactic acidosis, and stroke-like episodes (MELAS). They should be suspected in anyone …

Background and Objectives To identify factors associated with severe coronavirus disease
2019 (COVID-19), defined by hospitalization status, in patients with primary mitochondrial …

Myotonic dystrophy type 2 (DM2) is an autosomal dominant progressive disease involving
skeletal and cardiac muscle and brain. It is caused by a tetranucleotide repeat within the first …